Sen. Collins: I Hope Valeant Lowers Its Prices

The transcript discusses the potential changes in a company's pricing strategy following an investigation into drug price gouging. It highlights a controversial $67.4 million pay package and the company's response. The discussion also covers the broader pharmaceutical industry investigation and proposed legislative changes to prevent predatory pricing, including fast-tracking generic drug applications to enhance market competition.

What is the significance of the expressions of regret mentioned in the text?

What role does the FDA play in the context of the proposed bill mentioned by the speaker?